Immuron (Warrant)

YTD

ALL

Why Robinhood?

You can watch IMRNW and buy or sell other stocks, ETFs, and their options commission-free!

About IMRNW

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments.

CEO

Steven Lydeamore, MBA

CEOSteven Lydeamore, MBA

Employees

—

Employees—

Headquarters

Blackburn, Victoria (VIC)

HeadquartersBlackburn, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRNW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

IMRNW News

TipRanks 3d

Immuron Shareholders Back Ratification of Prior Share Issues at February 2026 EGM

The latest update is out from Immuron ( (IMRN) ). Immuron Limited reported to U.S. regulators that on 12 February 2026 its shareholders approved all resolution...

TipRanks 7d

Immuron reshapes finance and governance team with new CFO and company secretary

Immuron Limited ( (AU:IMC) ) has shared an update. Immuron Limited has announced senior leadership changes, with long-serving Chief Financial Officer and Compa...

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.